Mark W. Grinstaff

Mark W. Grinstaff (born May 23, 1965) is the William Fairfield Warren Distinguished Professor and a Professor of Biomedical Engineering, Chemistry, Materials Science and Engineering and Medicine, at Boston University, Director of the National Institutes of Health's T32 Program in [https://www.bu.edu/nano-bu/programs/doctoral-fellowships/trb/ Translational Research in Biomaterials] and Director of [https://www.bu.edu/nano-bu Nanotechnology Innovation Center]. [https://www.grinstaff.org Grinstaff group] is an interdisciplinary lab of scientists and engineers working on innovative projects. Grinstaff has developed new paradigms for translating rigorous academic research into practical applications, fostering intellectual advancement, economic growth, and enhanced clinical outcomes. His career is characterized by continuous exploration and innovation, with his discoveries influencing diverse research areas. Additionally, he is a co-founder of several companies and a co-inventor of several regulatory-approved drug and device products currently used in the clinic today. Provided by Wikipedia